Compounds > pirfenidone
Page last updated: 2024-08-23

pirfenidone and Dermatitis Medicamentosa

pirfenidone has been researched along with Dermatitis Medicamentosa in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamski, H; Arnouat, B; Droitcourt, C; Dupuy, A; Jouneau, S; Kerjouan, M; Le Garrec, M; Oger, E; Polard, E; Polat, A1
D'Arcy, C; De la Harpe Golden, P; Kelly, AS; Lally, A1
Ehlers-Tenenbaum, S; Herth, FJ; Heussel, CP; Kahn, N; Kreuter, M; Oltmanns, U; Palmowski, K; Puderbach, M; Schnabel, PA; Träger, A; Warth, A; Wenz, H; Wiebel, M1
Margaritopoulos, G1
Caruana, DM; Wylie, G1

Other Studies

5 other study(ies) available for pirfenidone and Dermatitis Medicamentosa

ArticleYear
Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.
    The British journal of dermatology, 2018, Volume: 178, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Pyridones

2018
Drug-induced lupus erythematosus secondary to pirfenidone.
    The British journal of dermatology, 2018, Volume: 178, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Idiopathic Pulmonary Fibrosis; Lupus Erythematosus, Systemic; Middle Aged; Pyridones

2018
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
    Respiration; international review of thoracic diseases, 2014, Volume: 88, Issue:3

    Topics: Acetylcysteine; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Disease Progression; Drug Eruptions; Drug Therapy, Combination; Expectorants; Fatigue; Female; Gastrointestinal Diseases; Germany; Humans; Idiopathic Pulmonary Fibrosis; Male; Medication Adherence; Middle Aged; Pyridones; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vital Capacity; Weight Loss

2014
Challenges in IPF diagnosis, current management and future perspectives: Patient case 2.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2015, Aug-03, Volume: 32 Suppl 1

    Topics: Adrenal Cortex Hormones; Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Eruptions; Follow-Up Studies; Hemoptysis; Humans; Hypertension; Idiopathic Pulmonary Fibrosis; Male; Pyridones; Risk Assessment; Severity of Illness Index; Tachycardia, Supraventricular; Tomography, X-Ray Computed; Treatment Outcome

2015
Cutaneous reactions to pirfenidone: a new kid on the block.
    The British journal of dermatology, 2016, Volume: 175, Issue:2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Facial Dermatoses; Hand Dermatoses; Humans; Male; Pulmonary Fibrosis; Pyridones; Recurrence

2016